Verrica Pharmaceuticals I... (VRCA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.66
0.02 (3.09%)
At close: Jan 17, 2025, 3:59 PM
0.68
2.63%
After-hours Jan 17, 2025, 05:32 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 69.55M | 34.27M | 15.75M | 10.69M | 9.24M | 89.81M | 8.66M | 527.00K |
Short-Term Investments | n/a | n/a | 54.60M | 54.78M | 52.78M | 79.54M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 410.00K | n/a | n/a | n/a |
Other Long-Term Assets | 452.00K | n/a | n/a | 3.75M | 830.00K | 1.84M | n/a | n/a |
Receivables | 4.42M | 487.00K | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 1.02M | -487.00K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.54M | 8.71M | 7.95M | 4.36M | 5.93M | 2.69M | 420.00K | 17.00K |
Total Current Assets | 77.53M | 39.12M | 74.33M | 65.47M | 64.98M | 89.81M | 9.08M | 544.00K |
Property-Plant & Equipment | 3.62M | 5.61M | 5.80M | 4.94M | 2.20M | 255.00K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.07M | 5.61M | 5.80M | 8.68M | 3.44M | 2.10M | n/a | n/a |
Total Assets | 81.60M | 44.72M | 80.13M | 74.15M | 68.42M | 91.91M | 9.08M | 544.00K |
Account Payables | 2.46M | 507.00K | 845.00K | 348.00K | 1.19M | 922.00K | 153.00K | 67.00K |
Deferred Revenue | n/a | n/a | n/a | 500.00K | n/a | n/a | n/a | -36.00K |
Short-Term Debt | 700.00K | 594.00K | 41.94M | 35.71M | 260.00K | n/a | n/a | n/a |
Other Current Liabilities | 13.86M | 2.36M | 3.27M | 2.92M | 1.91M | 1.55M | 463.00K | 352.00K |
Total Current Liabilities | 17.02M | 3.46M | 46.05M | 39.48M | 3.35M | 2.48M | 616.00K | 419.00K |
Long-Term Debt | 44.81M | 1.23M | 1.47M | 1.69M | 58.00K | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.79M |
Total Long-Term Liabilities | 44.81M | 1.23M | 1.47M | 35.31M | 58.00K | n/a | n/a | 2.79M |
Total Liabilities | 61.83M | 4.69M | 47.52M | 41.17M | 3.41M | 2.48M | 616.00K | 3.21M |
Total Debt | 45.51M | 1.53M | 43.41M | 35.31M | 188.00K | n/a | n/a | 36.00K |
Common Stock | 4.00K | 4.00K | 3.00K | 3.00K | 3.00K | 3.00K | 2.00K | 1K |
Retained Earnings | -230.45M | -163.45M | -138.97M | -103.89M | -61.19M | -33.08M | -12.44M | -2.68M |
Comprehensive Income | n/a | n/a | -29.00K | 1K | 20.00K | -17.00K | -15.51M | -1K |
Shareholders Equity | 19.76M | 40.03M | 32.60M | 32.99M | 65.02M | 89.43M | 8.47M | -2.66M |
Total Investments | n/a | n/a | 54.60M | 54.78M | 52.78M | 79.54M | n/a | n/a |